Phillip Scheinberg

13.9k total citations · 2 hit papers
153 papers, 7.1k citations indexed

About

Phillip Scheinberg is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Phillip Scheinberg has authored 153 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 97 papers in Hematology, 61 papers in Immunology and 31 papers in Genetics. Recurrent topics in Phillip Scheinberg's work include Hematopoietic Stem Cell Transplantation (69 papers), Platelet Disorders and Treatments (24 papers) and Complement system in diseases (23 papers). Phillip Scheinberg is often cited by papers focused on Hematopoietic Stem Cell Transplantation (69 papers), Platelet Disorders and Treatments (24 papers) and Complement system in diseases (23 papers). Phillip Scheinberg collaborates with scholars based in United States, Brazil and United Kingdom. Phillip Scheinberg's co-authors include Neal S. Young, Rodrigo T. Calado, Colin O. Wu, Olga Núñez, Barbara Weinstein, Daniel C. Douek, Elaine M. Sloand, Angélique Biancotto, Bogdan Dumitriu and David A. Price and has published in prestigious journals such as New England Journal of Medicine, JAMA and Journal of Clinical Oncology.

In The Last Decade

Phillip Scheinberg

138 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Current concepts in the pathophysiology and treatment of aplastic anemia

2006 642 citations Neal S. Young, Rodrigo T. Calado et al. Blood profile →
Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia

2017 337 citations Phillip Scheinberg, Bogdan Dumitriu et al. New England Journal of Medicine profile →

Peers

Countries citing papers authored by Phillip Scheinberg

Since Specialization

Citations

This map shows the geographic impact of Phillip Scheinberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Phillip Scheinberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Phillip Scheinberg more than expected).

Fields of papers citing papers by Phillip Scheinberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Phillip Scheinberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Phillip Scheinberg. The network helps show where Phillip Scheinberg may publish in the future.

Co-authorship network of co-authors of Phillip Scheinberg

This figure shows the co-authorship network connecting the top 25 collaborators of Phillip Scheinberg. A scholar is included among the top collaborators of Phillip Scheinberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Phillip Scheinberg. Phillip Scheinberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Pharmacokinetic characterization and exposure–response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria 2025 ·British Journal of Clinical Pharmacology ·Valérie Cosson, Rong Fu, Austin Kulasekararaj, Jun‐ichi Nishimura, Jens Panse, Alexander Röth, Phillip Scheinberg, (unknown), Sung‐Soo Yoon, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Sasha Sreckovic, (unknown), Zilu Zhang, (unknown), (unknown)	0
2	Phase III COMMODORE 2 and 1 Trials: Characterization of Breakthrough Hemolysis Events in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Treated with Crovalimab or Eculizumab 2024 ·Blood ·Austin Kulasekararaj, Jarosław Czyż, Catherine Flynn, (unknown), Marek Hus, (unknown), Erfan Nur, Phillip Scheinberg, Yasutaka Ueda, (unknown), (unknown), (unknown), (unknown), Alice Chinghsuan Chang, Sammy Chebon, Alexander Röth	1
3	Crovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscape 2024 ·Immunotherapy ·Alexander Röth, Austin Kulasekararaj, Phillip Scheinberg, Jun‐ichi Nishimura	1
4	Activity and safety of eltrombopag in combination with cyclosporin A as first‑line treatment of adults with severe aplastic anaemia (SOAR): a phase 2, single-arm study 2024 ·The Lancet Haematology ·Phillip Scheinberg, Carlo Finelli, (unknown), Carlos Vallejo, Lalita Norasetthada, Rodrigo T. Calado, Mehmet Turgut, Régis Peffault de Latour, Ulrike Kriemler‐Krahn, (unknown), (unknown), Jun‐Ho Jang	7
5	Categorization of Hematological Responses to Oral Iptacopan Monotherapy in Anti-C5-Treated Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) and Persistent Anemia in the Phase III APPLY-PNH Trial and Complement Inhibitor-Naïve Patients in the Phase III APPOINT-PNH Trial 2023 ·Blood ·Antonio M. Risitano, Bing Han, Austin Kulasekararaj, Yasutaka Ueda, Phillip Scheinberg, Carlos de Castro, Jaroslaw P. Maciejewski, Josefin Snellman, Ranjan Tiwari, Marion Dahlke, Régis Peffault de Latour	4
6	Targeted therapy with nanatinostat and valganciclovir in recurrent EBV-positive lymphoid malignancies: a phase 1b/2 study 2023 ·Blood Advances ·Bradley M. Haverkos, Önder Alpdoğan, Robert A. Baiocchi, Jonathan E. Brammer, Tatyana Feldman, Marcelo Capra, Elizabeth Brém, (unknown), Phillip Scheinberg, Juliana Pereira, Leyla Shune, Erel Joffe, Patricia A. Young, Susan E. Spruill, (unknown), (unknown), Ivor Royston, Douglas V. Faller, (unknown), Pierluigi Porcu	25
7	Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. I: Structuring centers for the multidisciplinary clinical administration and management of CAR-T cell therapy patients 2021 ·Hematology Transfusion and Cell Therapy ·Diego V. Clé, Alexandre V. Hirayama, Alvaro J. Alencar, Luciano J. Costa, (unknown), (unknown), Ana Cordeiro, (unknown), (unknown), Marcos de Lima, Phillip Scheinberg, Renato Cunha	3
8	Thromboembolic and bleeding events in intensive care unit patients with COVID-19: results from a Brazilian tertiary hospital 2021 ·International Journal of Infectious Diseases ·(unknown), Cleyton Zanardo de Oliveira, (unknown), (unknown), (unknown), Danielle Leão Cordeiro de Farias, Phillip Scheinberg, Viviane Cordeiro Veiga	3
9	Rabbit antithymocyte globulin dose does not affect response or survival as first-line therapy for acquired aplastic anemia: a multicenter retrospective study 2018 ·Annals of Hematology ·Diego V. Clé, Elias Hallack Atta, (unknown), (unknown), Mariana Bonduel, Gabriela Sciuccati, (unknown), (unknown), (unknown), Sara T.O. Saad, Nelson Hamerschlak, (unknown), (unknown), Antônio Pazin‐Filho, Phillip Scheinberg, Rodrigo T. Calado	13
10	Horse antithymocyte globulin as salvage therapy after rabbit antithymocyte globulin for severe aplastic anemia 2014 ·American Journal of Hematology ·Phillip Scheinberg, Danielle Townsley, Bogdan Dumitriu, Priscila Scheinberg, Barbara Weinstein, Olga Rios, Colin O. Wu, Neal S. Young	22
11	Prolonged cyclosporine administration after antithymocyte globulin delays but does not prevent relapse in severe aplastic anemia 2014 ·American Journal of Hematology ·Phillip Scheinberg, Olga Rios, Priscila Scheinberg, Barbara Weinstein, Colin O. Wu, Neal S. Young	33
12	Successful platelet count recovery in lupus-associated thrombocytopenia with the thrombopoietin agonist eltrombopag 2014 ·Clinical Rheumatology ·Phillip Scheinberg, Cristiane Carvalho Singulane, (unknown), Morton Scheinberg	11
13	Horse versus Rabbit Antithymocyte Globulin in Acquired Aplastic Anemia 2011 ·New England Journal of Medicine ·Phillip Scheinberg, Olga Núñez, Barbara Weinstein, Priscila Scheinberg, Angélique Biancotto, Colin O. Wu, Neal S. Young	327
14	Cyclosporine Taper Does Not Prevent Relapse in Severe Aplastic Anemia 2011 ·Blood ·Phillip Scheinberg, Olga Núñez, Priscila Scheinberg, Barbara Weinstein, Colin O. Wu, Neal S. Young	4
15	Alloreactivity Across HLA Barriers Is Mediated by Both Naïve and Antigen-Experienced T Cells 2011 ·Biology of Blood and Marrow Transplantation ·J. Joseph Melenhorst, Phillip Scheinberg, Ann Williams, David R. Ambrozak, Keyvan Keyvanfar, Melody Smith, J. Philip McCoy, Nancy F. Hensel, Daniel C. Douek, A. John Barrett	25
16	Alemtuzumab (Campath) Monotherapy for Severe Aplastic Anemia. 2010 ·Blood ·Phillip Scheinberg, (unknown), Colin O. Wu, (unknown), (unknown), Olga Núñez, Elaine M. Sloand, Neal S. Young	4
17	A Randomized Trial of Horse Versus Rabbit Antithymocyte Globulin In Severe Acquired Aplastic Anemia 2010 ·Blood ·Phillip Scheinberg, Colin O. Wu, Priscila Scheinberg, Barbara Weinstein, Olga Núñez, Elaine M. Sloand, Neal S. Young	5
18	Granulocyte transfusions in severe aplastic anemia: an eleven-year experience 2009 ·Haematologica ·Karen Quillen, (unknown), Phillip Scheinberg, (unknown), Thomas J. Walsh, C. O. Wu, Susan F. Leitman	64
19	TCR β-Chain Sharing in Human CD8+ T Cell Responses to Cytomegalovirus and EBV 2008 ·The Journal of Immunology ·Vanessa Venturi, (unknown), Tedi E. Asher, Kristin Ladell, Phillip Scheinberg, Ethan Bornstein, David van Bockel, Anthony D. Kelleher, Daniel C. Douek, David A. Price, Miles P. Davenport	83
20	Techniques to improve the direct ex vivo detection of low frequency antigen‐specific CD8⁺ T cells with peptide‐major histocompatibility complex class I tetramers 2008 ·Cytometry Part A ·Pratip K. Chattopadhyay, J. Joseph Melenhorst, Kristin Ladell, Emma Gostick, Phillip Scheinberg, A. John Barrett, Linda Wooldridge, Mario Roederer, Andrew K. Sewell, David A. Price	45

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact